Table 2. MCV coverage assessment of different age groups*.
Age range | 0 dose | 1 dose | ≥2 doses | |||
---|---|---|---|---|---|---|
No. | Percentage (95% CI) | No. | Percentage (95% CI) | No. | Percentage (95% CI) | |
8–17 months | 22 | 19.6 (12.7–28.2) | 62 | 55.4 (45.7–64.8) | 28 | 25.0 (17.3–34.1) |
18–23 months | 2 | 3.5 (0.4–12.1) | 20 | 35.1 (22.9–48.9) | 35 | 61.4 (47.6–74) |
≥24 months | 7 | 1.9 (0.8–3.8) | 25 | 6.7 (4.4–9.7) | 341 | 91.4 (88.1–94.1) |
sum | 31 | 5.7 (3.9–8) | 107 | 19.7 (16.5–23.3) | 404 | 74.5 (70.7–78.2) |
*The MCV doses include both routine immunization doses and SIA/SVA doses.